Prenatal and New-born Genetic Testing Market Trends

Prenatal and New-born Genetic Testing Market Trends

The prevalence of genetic diseases and chromosomal abnormalities has increased rapidly across the globe in the last few years. Around 350 million people suffer from some of the other genetic and rare diseases across the globe. According to the World Health Organization (WHO), genetic disorders and chromosomal abnormalities are reported in approximately 2 to 5% of live births. These disorders are responsible for around 30% of pediatric hospital visits and account for 50% of pediatric deaths in developed economies. Increasing prevalence of these disorders would increase the target population for market, thereby presenting the industry progression.
 

Genetic and congenital conditions increase the disease burden and cause significant mortalities among prenatal and newborn babies. Chromosomal abnormalities are referred to as one of the leading factors responsible for infant mortality in the UAE, Bahrain, Oman, Kuwait and Qatar. Several studies conducted in Saudi Arabia infer that majority of prenatal mortalities were caused due to congenital malformations. Moreover, genetic and chromosomal ailments account for several disabilities such as mental handicap, blindness and deafness. Similarly, in India, genetic diseases and chromosomal abnormality occurs among 25-60 per 1,000 births and is one of the leading factors for child mortality. Genetic factors also augment the incidence of multifactorial disorders and are responsible for progressively rising inherited cardiovascular ailments in many countries. Growing prevalence of chromosomal abnormalities, associated conditions and genetic disorders will intensify the prenatal and new-born genetic testing market size during the forecast timeframe.
 

The screening segment in the prenatal and new-born genetic testing market is projected to expand at an 11.4% growth rate through 2027 led by technological advancements, surge in use of screening during pregnancy and growing awareness regarding birth defects. Screening tests are used in determination of inherited, congenital birth defects and performed during & after pregnancy. Pregnancy after 35 years of age increases the risk of giving birth to a baby with chromosomal defects and the risk increases with growing age. Upsurge in geriatric pregnancy will further foster the demand for acceptance of screening genetic tests. Technological advancements in the genetic screening tests such as the non-invasive prenatal testing (NIPT) would further channelize the industry size.